Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Toraymyxin Launch in China?

<< Previous

Bullboard Posts

Next >>

Post by gebremeskelon Nov 08, 2024 9:38am

153 Views

Post# 36302953

Toraymyxin Launch in China?

Toraymyxin is available in India, Korea, Singapore, Taiwan and Thailand - but not mainland China

( see: https://www.toraymyxin.toray/en/worldwide/ )

It looks like Vantive may have plans to tackle that large market.

https://x.com/ShLetsMeet/status/1854705502644772959

"Exciting new products and tech are making their debut at #CIIE!...Vantive's PrisMax, a next-gen blood purification system tailored for China's clinical needs, and Edwards Lifesciences' world-first MITRIS RESILIA mitral valve are also grabbing attention"